Sera Prognostics tumbles on $50 mln stock offering

Sera Prognostics

11/02/2025 14:16

** Sera Prognostics Inc's  SERA.O  shares down 15.3% premarket
to $3.77, over 1-yr low, after overnight follow-on priced
    ** Salt Lake City-based women's health firm late Mon
announced 12.5 mln shares, including 11.25 mln pre-funded
warrants, at $4 for $50 mln gross proceeds
    ** Offering price is 10.1% discount to last sale
    ** Co intends to use net offering proceeds to expand
commercial infrastructure in the U.S., accelerate preparations
for expansion in the European Union, fund additional studies to
increase adoption of its blood test to predict preterm birth
risks, PreTRM, including a potential submission to U.S. FDA for
broad approval
    ** Jefferies, TD Cowen and William Blair are jt bookrunners,
along with RBC
    ** Co has ~33.77 mln shares outstanding for market cap of
~$150 mln and ~28.6 mln shares of free float, per LSEG
    ** SERA shares, which have fallen 6 of the past 7 sessions,
have declined 45% YTD through Mon close

(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@tr.com 1-646-279-6380))